John Tagliamonte

John Tagliamonte is a seasoned professional in the biotechnology and pharmaceuticals sector, currently serving as an Advisory Board Member at Adecto Pharmaceuticals and PhagePro, and as a Senior Business Advisor at HARBOUR BIOMED. Previous roles include CEO of Mellitus, LLC, where operations and financing were spearheaded, and Co-Founder of Tantu Therapeutics, Inc., which focuses on innovative therapies for inflammatory bowel disease. John has also held significant positions such as Chief Operating Officer at WntRx Pharmaceuticals and Chief Business Officer at Oxyrane, contributing to advancements in cancer and neurodegenerative disease treatments. Educational achievements include a B.S. in Molecular Biology from Tufts University and an MBA in Global Marketing from Boston College.